Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Peters

Showing results (31-40 of 218) with videos related to

Pageof 22
Sort By:
Annals of Internal Medicine|June 16, 2015
ACP Journal Club. Review: Adding tiotropium to ICSs alone or with LABAs improves pulmonary function in asthmaDiego J Maselli, Jay I Peters
Respiratory Care|March 28, 2006
Congestive heart failure: Diagnosis, pathophysiology, therapy, and implications for respiratory careMichael S Figueroa, Jay I Peters
Respiratory Care|May 26, 2018
Medication Regimens for Managing Acute AsthmaDiego J Maselli, Jay I Peters
Annals of Internal Medicine|June 19, 2018
Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbationsDiego J Maselli, Jay I Peters
Life Sciences|January 1, 1977
Electrophysiological signs of differential tolerance development to morphine in selected areas of the rabbit brainR I Peters, W R Klemm
Experimental Neurology|July 1, 1980
Serotonergic-catecholaminergic antagonism and locomotor controlR I Peters, K M Meyers
Clinics in Chest Medicine|March 1, 1994
Pathophysiology of acute respiratory failureK E Greene, J I Peters
Annals of Internal Medicine|October 20, 2017
In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 monthsDiego J Maselli, Jay I Peters
Annals of Internal Medicine|April 5, 2013
ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPDSandra G Adams, Jay I Peters
Annals of Internal Medicine|September 18, 2013
5 days of prednisone was noninferior to 14 days in patients with acute COPD exacerbationDiego J Maselli, Jay I Peters
Pageof 22

Showing results (31-40 of 218) with videos related to

Sort By:
Pageof 22
Annals of Internal Medicine|June 16, 2015
ACP Journal Club. Review: Adding tiotropium to ICSs alone or with LABAs improves pulmonary function in asthmaDiego J Maselli, Jay I Peters
Respiratory Care|March 28, 2006
Congestive heart failure: Diagnosis, pathophysiology, therapy, and implications for respiratory careMichael S Figueroa, Jay I Peters
Respiratory Care|May 26, 2018
Medication Regimens for Managing Acute AsthmaDiego J Maselli, Jay I Peters
Annals of Internal Medicine|June 19, 2018
Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbationsDiego J Maselli, Jay I Peters
Life Sciences|January 1, 1977
Electrophysiological signs of differential tolerance development to morphine in selected areas of the rabbit brainR I Peters, W R Klemm
Experimental Neurology|July 1, 1980
Serotonergic-catecholaminergic antagonism and locomotor controlR I Peters, K M Meyers
Clinics in Chest Medicine|March 1, 1994
Pathophysiology of acute respiratory failureK E Greene, J I Peters
Annals of Internal Medicine|October 20, 2017
In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 monthsDiego J Maselli, Jay I Peters
Annals of Internal Medicine|April 5, 2013
ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPDSandra G Adams, Jay I Peters
Annals of Internal Medicine|September 18, 2013
5 days of prednisone was noninferior to 14 days in patients with acute COPD exacerbationDiego J Maselli, Jay I Peters
Pageof 22